Inventiva (IVA) Other Accumulated Expenses (2019 - 2025)

Inventiva's (IVA) quarterly Other Accumulated Expenses came in at $17.2 billion in Q2 2025, up 273225.25% year-on-year from N/an in Q2 2024, and up 86.86% quarter-over-quarter from $9.2 billion in Q4 2024.

Inventiva (IVA) Other Accumulated Expenses (2019 - 2025) Analysis & Trends

Inventiva's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $17.2 billion for Q2 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 273225.25% year-over-year to $17.2 billion in Q2 2025; TTM through Jun 2025 was $17.2 billion, a 273225.25% increase from a year earlier, with the FY2024 full-year figure at $9.2 billion, up 119108.59% from the prior year.
  • Other Accumulated Expenses grew to $17.2 billion in Q2 2025 per IVA's latest filing, from $9.2 billion in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $17.2 billion in Q2 2025 and bottomed at $5.4 million in Q2 2023.
  • The 5-year median for Other Accumulated Expenses is $8.2 million (2023), against an average of $3.9 billion.
  • Across the five-year window, Other Accumulated Expenses tumbled 99.93% in 2022 and surged 273225.25% in 2025, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $7.8 billion in 2021, then tumbled by 99.93% to $5.6 million in 2022, then jumped by 37.76% to $7.7 million in 2023, then soared by 119108.59% to $9.2 billion in 2024, then surged by 86.86% to $17.2 billion in 2025.
  • Per Business Quant, the three latest IVA Other Accumulated Expenses figures stand at $17.2 billion (Q2 2025), $9.2 billion (Q4 2024), and $6.3 million (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Inventiva 854.62 Mn 854.62 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 17.17 Bn
Dec 31, 2024 9.19 Bn
Jun 30, 2024 6.28 Mn
Dec 31, 2023 7.71 Mn
Jun 30, 2023 5.42 Mn
Dec 31, 2022 5.60 Mn
Jun 30, 2022 5.01 Bn
Dec 31, 2021 7.77 Bn
Jun 30, 2021 5.43 Mn
Mar 31, 2021 8.71 Mn
Dec 31, 2020 8.15 Mn
Jun 30, 2020 5.88 Mn
Dec 31, 2019 5.53 Mn